DexCom Inc. DXCM recently announced the direct connectivity of the Dexcom G7 Continuous Glucose Monitoring (CGM) system with the Apple Watch. This added feature is now available to users in the United ...
Beginning Dec. 18, iLet users will have the option of using a Dexcom G7 CGM System. CONCORD, MA / ACCESSWIRE / December 7, 2023 / Beta Bionics, Inc., a pioneering leader in the development of advanced ...
Ontario residents eligible for ODB and living with type 1 or type 2 diabetes and using insulin are now covered for Dexcom G7. Ontario residents eligible for ODB and living with type 1 or type 2 ...
SAN DIEGO - DexCom , Inc. (NASDAQ:DXCM), a leader in real-time continuous glucose monitoring (CGM) systems, has announced the launch of a feature allowing its Dexcom (NASDAQ:DXCM) G7 CGM System to ...
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will ...
Shay Speakman-Brown, Dexcom Head of Market Access discusses diabetes management. The views expressed here are not necessarily those of The Scotsman and it is recommended to always seek NHS advice ...
Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers. * Dexcom Smart Basal is FDA cleared and now the ...
SAN DIEGO - DexCom, Inc. (NASDAQ:DXCM) announced Wednesday that the FDA has cleared Dexcom Smart Basal, the first CGM-integrated basal insulin dosing optimizer for adults with Type 2 diabetes using ...
SAN DIEGO - DexCom, Inc. (NASDAQ:DXCM), a $26.12 billion medical device company with 11.34% revenue growth over the last twelve months, announced the FDA clearance of its Dexcom G7 15 Day Continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback